Umino K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Minakata D, et al. Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 2019. 60. 8. 1-8
Ryosuke Uchibori, Takeshi Teruya, Hiroyuki Ido, Ken Ohmine, Yoshihide Sehara, Masashi Urabe, Hiroaki Mizukami, Junichi Mineno, Keiya Ozawa. Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen Receptor. Molecular therapy oncolytics. 2019. 12. 16-25
Mashima K, Ikeda T, Toda Y, Ito S, Umino K, Minakata D, Nakano H, Morita K, Yamasaki R, Kawasaki Y, et al. Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome. Leukemia & lymphoma. 2019. 60. 3. 703-710
Clinical development of chimeric antigen receptor-modified T-cell therapy for Acute Lymphoblastic Leukemia
(7th Thai Society of Hematology International Symposium 2019)
Clinical development of CAR therapy in patients with hematological malignancies in Japan: the current status and challenges
(The 9th Asian Cellular Therapy Organization Meeting 2018)
Professional career (1)：
医学博士 (自治医科大学)
Work history (1)：
2014 - Jichi Medical University School of Medicine
Association Membership(s) (6)：
Society of Immunotherapy for Hematological Malignancies
, The Japanese Society of Myeloma
, THE JAPANESE CANCER ASSOCIATION
, The Japan Society of Gene and Cell Therapy
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, THE JAPANESE SOCIETY OF HEMATOLOGY
